News

President Kim Brooks, Dr. Pat Croskerry appointed to Order of Canada

President Kim Brooks, Dr. Pat Croskerry appointed to Order of Canada

The latest set of appointments to one of Canada's highest honours has a number of familiar Dal faces, including President Kim Brooks and retired Faculty of Medicine faculty member Dr. Pat Croskerry.  Read more.

Featured News

Matt Reeder, Tanis Trainor, and Ryan McNutt
Friday, December 19, 2025
Our 2025 Year in Review brings together 45 stories of innovation, achievement, and community, offering a vivid snapshot of the moments and milestones that helped shape a transformative year.
Matt Reeder
Wednesday, December 17, 2025
Ä¢¹½AV leapt forward in the 2025 Global Ranking of Academic Subjects, with impressive gains across multiple disciplines.
Matt Reeder
Wednesday, November 19, 2025
From varsity swimming to ocean-tech entrepreneurship, Isaac Bahler’s path to Oxford reflects a passion for turning climate research into real-world solutions.

Archives - News

Matt Reeder
Monday, November 28, 2022
Ä¢¹½AV's Accessibility Plan, released this past summer, lays out a detailed roadmap for ensuring the university meets Nova Scotia's goal of being fully accessible by 2030.
Andrew Riley
Thursday, November 24, 2022
Last night’s 20th annual Discovery Awards, co-presented by Ä¢¹½AV, was a moment to celebrate university innovators who are inspiring the next generation of Nova Scotian scientists.
Staff
Wednesday, November 23, 2022
On Tuesday, the Board of Governors approved a new international tuition model for future students featuring a tuition guarantee and fees better aligned with Dal’s national peers — all of which is poised to bring significant investments in Dal’s student experience.
Staff
Wednesday, November 23, 2022
Cheryl Fraser, a two-time Dal alum who is current is currently Chief Talent Officer and Vice-President Communications at Crombie REIT, has been appointed Chair of the Ä¢¹½AV Board of Governors for a three-year term.
Alison Auld
Tuesday, November 22, 2022
A pair of post-doctoral fellows in Dal's Department of Microbiology and Immunology have shown that an existing drug used to treat cancer and other illnesses also holds the promise of effectively treating people infected with the virus that causes COVID-19.